|本期目录/Table of Contents|

[1]曾 艳,赵 青,周 静,等.mTORC2通路调控CD4+CD25highTreg在糖尿病肾病大鼠中的研究[J].福建医科大学学报,2019,53(03):152-157.
 ZENG Yan,ZHAO Qing,ZHOU Jing,et al.Study of mTORC2 Pathway on CD4+CD25highTreg in Diabetic Nephropathy[J].Journal of Fujian Medical University,2019,53(03):152-157.
点击复制

mTORC2通路调控CD4+CD25highTreg在糖尿病肾病大鼠中的研究(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第53卷
期数:
2019年03期
页码:
152-157
栏目:
论著
出版日期:
2019-06-30

文章信息/Info

Title:
Study of mTORC2 Pathway on CD4+CD25highTreg in Diabetic Nephropathy
文章编号:
1672-4194(2019)03-0152-06
作者:
曾 艳 赵 青 周 静 李秋月
南昌大学 第一附属医院肾内科,南昌 330006
Author(s):
ZENG Yan ZHAO Qing ZHOU Jing LI Qiuyue
Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China
关键词:
糖尿病肾病 抗原 CD4 T淋巴细胞
Keywords:
diabetic nephropathies antigens CD4 T-lymphocytes
分类号:
R331.125; R392.1; R692.39
DOI:
-
文献标志码:
A
摘要:
目的 观察哺乳动物雷帕霉素靶蛋白(mTOR)通路阻断剂对糖尿病肾病(DN)大鼠CD4+CD25highTreg的影响,探讨调节性T细胞(Treg)在DN中的可能机制。 方法 以正常大鼠作为对照组(A组),DN大鼠随机分为模型组(B组)、FK506干预组(C组)及ku0063794干预组(D组)。第4,8周时分别检测肾脏病理、肾组织mTOR、Raptor蛋白水平、Rictor、血白细胞介素-17(IL-17)、转化生长因子-β1(TGF-β1)和CD4+CD25highTreg。 结果(1)4,8周时,B组的mTOR,Raptor和Rictor水平较A组均明显升高(P<0.05); 4周时,C组的mTOR下降,低于B组(P<0.05); 8周时,C,D组均下降,低于B组(P<0.001); 4,8周时,C,D组的Raptor均下降低于B组(P<0.05); 4周时,C,D组的Rictor均低于B组(P<0.05),8周时进一步下降,与A组比较差别无统计学意义,C,D组间比较差别无统计学意义。(2)4,8周时,B组的CD4+CD25highTreg明显低于A组(P<0.05),C,D组4周后逐步回升,高于B组(P<0.05); 8周时进一步升高,均高于4周时(P<0.05); C,D组间比较差别无统计学意义。(3)C,D组的病理评分较B组均降低(P<0.05),组间比较差别无统计学意义。(4)4,8周时,B组的血TGF-β1和IL-17均高于A组(P<0.05),C,D组下降(P<0.05); 4,8周时C组的TGF-β1低于D组(P<0.05);(5)8周时,B组大鼠的Rictor与CD4+CD25high Treg呈负相关(P<0.05),与TGF-β1,IL-17及病理评分呈正相关(P<0.05); Raptor与病理评分呈正相关(P<0.05),与CD4+CD25high Treg,TGF-β1及IL-17均无相关性(P>0.05)。 结论 CD4+CD25highTreg可能受Rictor-mTOR通路调控,参与DN的发病。
Abstract:
Objective To observe the effect of mammalian target of rapamycin(mTOR)pathway blocker on CD4+CD25highTreg in diabetic nephropathy(DN)rats, and to explore the possible mechanism of Regulatory T cell(Treg)in DN. Methods DN rats were randomly divided into model group(group B), FK506 intervention group(group C), and ku0063794 intervention group(group D), with normal rats as Control(Group A). Renal pathology, mTOR, Raptor, Rictor of renal tissue, serum interleukin-17(IL-17), transforming growth factor-β1(TGF-β1), and blood CD4+CD25highTreg were detected at 4th and 8th weeks. Results(1)mTOR, Raptor and Rictor in group B were significantly higher than those in group A at the 4th and 8th weeks(P<0.05). The mTOR in group C decreased at 4th week, which was lower than that in the group B(P<0.05). mTOR in groups C and D were lower than that in group B at 8th week(P<0.001). The Raptor in groups C and D were lower than that in B group at 4th and 8th weeks(P<0.05). The Rictor of the two groups(C and D)was lower than that of B group at 4th week(P<0.05). After 8 weeks, there was no difference in Rictor between groups C and D.(2)CD4+CD25highTreg in group B was significantly lower than that in group A at 4th and 8th weeks(P<0.05). CD4+CD25highTreg in groups C and D gradually recovered after 4 weeks, higher than in group B(P<0.05); and it further increased at 8th week, higher than that at 4th week(P<0.05); There was no difference between groups C and D.(3)Pathological scores of the groups C and D were lower than that of group B(P<0.05). There was no difference between the groups C and D.(4)Serum TGF-β1 and IL-17 in group B were higher than those in group A at 4th and 8th weeks(P<0.05), and they decreased after intervention(P<0.05). TGF-β1 in group C was lower than that in group D at 4th and 8th weeks(P<0.05).(5)At 8th week, Rictor was negatively correlated with CD4+CD25high Treg(P<0.05), and positively correlated with TGF-β1, IL-17, and pathological scores(P<0.05). Raptor was positively correlated with pathological scores(P<0.05), and there was no correlation with CD4+CD25high Treg, TGF-β1, or IL-17(P>0.05). Conclusion CD4+CD25highTreg may be regulated by the Rictor-mTOR pathway and participate in the pathogenesis of diabetic nephropathy.

参考文献/References:

[1] Zhang C,Xiao C,Wang P,et al.The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy[J]. Hum Immunol,2014,75(4):289-296.[2] Zeng C,Shi X,Zhang B,et al.The imbalance of Th17/Th1/Treg in patients with type 2 diabetes: relationship with metabolic factors and complications[J]. J Molecular Medicine,2012,90(2):175-186.[3] 王 野,钱 程.mTOR 抑制剂-雷帕霉素对 T 细胞功能调控的研究进展[J].国际免疫学杂志,2011,34(5):281-284.[4] 吴小川,易著文,赵维玲,等.紫癜性肾炎患儿肾脏病理程度评分与临床关系的探讨[J].中华肾脏病杂志,2000,16(5):335-336.[5] Godel M,Hartleben B,Herbach N, et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice[J]. J Clin Invest,2011,121(6):2197-2209.[6] Lu M K,Gong X G,Guan K L. mTOR in podocyte function is rapamycin good for diabetic nephropathy[J]? Cell Cycle,2011,10(20):3415-3416.[7] 钟梅芳,赵 青,李秋月,等.mTOR信号通路在糖尿病肾病大鼠足细胞损伤中的研究[J].广东医学,2017,38(23):3561-3565.[8] Chen G,Dong Z,Liu H,et al.mTOR signaling regulates protective activity of transferred CD4+Foxp3+ T cells in repair of acute kidney injury[J]. J Immunol,2016,197(10):3917-3926.[9] 毕逢辰,保 莉,罗红艳,等.Cdk5和TGF-β1在糖尿病肾病足细胞中的表达及其作用[J].宁夏医学杂志,2015,37(3):206-208.[10] Ma X,Ding J,Min H,et al.Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin[J]. Int Immunopharmacol,2013,17(3):752-758.[11] Bettelli E,Oukka M,Kuchroo V K. TH-17 cells in the circle of immunity and autoimmunity[J]. Nat Immunol,2007,8(4):345-350.[12] 王 莉,李 秋,王莉佳,等.原发性肾病综合征患儿外周血Th17与CD4+CD25+ Foxp3调节性T细胞的水平[J].细胞与分子免疫学杂志,2010,26(8):1413-1415.

相似文献/References:

[1]林俊,朱益华.Brn-3a标记大鼠视网膜神经节细胞的实验研究[J].福建医科大学学报,2014,48(02):75.
 LIN Jun,ZHU Yihua.An Experimental Study on Brn-3a as a Marker of Retinal Ganglion Cells[J].Journal of Fujian Medical University,2014,48(03):75.
[2]谢建伟,黄昌明,郑朝辉,等.CD44v6与胃癌淋巴结转移及预后关系研究[J].福建医科大学学报,2015,49(03):145.
 XIE Jianwei,HUANG Changming,ZHENG Chaohui,et al.The Expression and Clinical Value of CD44v6 in Gastric Cancer[J].Journal of Fujian Medical University,2015,49(03):145.
[3]陆 俊,曹龙龙,黄昌明,等.Ezrin蛋白在胃癌增殖侵袭过程中的作用及其机制初探[J].福建医科大学学报,2015,49(05):273.
 LU Jun,CAO Longlong,HUANG Changming,et al.The Effect of Ezrin Protein on the Growth and Invasiveness in Gastric Cancer[J].Journal of Fujian Medical University,2015,49(03):273.
[4]谢建伟,黄昌明,郑朝辉,等.CD44v6在胃神经内分泌癌中的表达及其意义[J].福建医科大学学报,2015,49(05):280.
 XIE Jianwei,HUANG Changming,ZHENG Chaohui,et al.The Expression and Clinical Value of CD44v6 in Gastric Neuroendocrine Carcinoma[J].Journal of Fujian Medical University,2015,49(03):280.
[5]车耀健,赵宁宁,胡 妍,等.抗EGFR/CD3双特异性抗体的制备与功能的初步研究[J].福建医科大学学报,2017,51(06):369.
 CHE Yaojian,ZHAO Ningning,HU Yan,et al.Preparation and Preliminary Investigation of Function of Anti-EGFR/CD3 Bispecific Antibody[J].Journal of Fujian Medical University,2017,51(03):369.
[6]叶 琴,黄 焱,朱益华.依那西普对糖尿病大鼠视网膜凋亡通路中Fas, TNF-α及caspase-8表达的影响[J].福建医科大学学报,2019,53(02):94.
 YE Qin,HUANG Yan,ZHU Yihua.Effect of Etanercept on The Expression of Fas, TNF-α, and Caspase-8 in Retinal of Diabetic Rats[J].Journal of Fujian Medical University,2019,53(03):94.

备注/Memo

备注/Memo:
收稿日期: 2018-07-02;基金项目: 江西省自然科学基金(20161BAB205233);作者简介: 曾 艳,女,主治医师,医学硕士;通讯作者: 李秋月. Email: xuanxuan19972005@sina.com
更新日期/Last Update: 2019-06-30